Skip to main content
. 2024 Oct 2;24:101870. doi: 10.1016/j.fochx.2024.101870

Fig. 4.

Fig. 4

The establishment of the IR HepG2 cell model and effect of MEPS-I on HepG2 cell viability and glucose consumption. (A) Effect of MEPS-I on IR-HepG2 cell viability; (B) Effect of different insulin concentrations on glucose consumption of cells under 36 h treatment conditions; (C) Effect of different incubation times on glucose consumption of HepG2 cells at 10−7 M insulin concentration; (D) Effect of MEPS-I on HepG2 cell glucose consumption.